| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,691 |
5,668 |
$299K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,885 |
7,808 |
$275K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,587 |
1,374 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
952 |
643 |
$18K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
143 |
134 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
753 |
690 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
264 |
228 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
66 |
61 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
82 |
79 |
$2K |
| 99406 |
|
281 |
231 |
$2K |
| 99442 |
|
25 |
24 |
$1K |
| 87634 |
|
20 |
20 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
83 |
76 |
$793.12 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
61 |
53 |
$759.46 |
| 96127 |
|
163 |
153 |
$695.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
603 |
546 |
$630.37 |
| 90632 |
|
36 |
32 |
$598.87 |
| 90656 |
|
24 |
21 |
$363.47 |
| 81025 |
|
43 |
39 |
$309.07 |
| 86308 |
|
35 |
35 |
$245.54 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
483 |
428 |
$169.50 |
| 90461 |
|
17 |
13 |
$143.84 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14 |
14 |
$139.42 |
| 99348 |
|
14 |
13 |
$58.86 |
| 81003 |
|
56 |
50 |
$27.81 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$20.93 |
| 1036F |
|
614 |
541 |
$0.13 |
| 3078F |
|
26 |
26 |
$0.07 |
| 1034F |
|
381 |
335 |
$0.07 |
| 1159F |
|
456 |
419 |
$0.06 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
245 |
216 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
585 |
496 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
46 |
41 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
26 |
26 |
$0.00 |
| G8711 |
Prescribed antibiotic on or within 3 days after the episode date |
13 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
192 |
164 |
$0.00 |